Efficient editing of the CXCR4 locus using Cas9 ribonucleoprotein complexes stabilized with polyglutamic acid
- Authors: Golubev D.S.1, Komkov D.S.1,2, Shepelev M.V.1, Mazurov D.V.1,3, Kruglova N.A.1
-
Affiliations:
- Center for Precision Genome Editing and Genetic Technologies for Biomedicine
- Ben-Gurion University of the Negev
- University of Minnesota
- Issue: Vol 514, No 1 (2024)
- Pages: 85-90
- Section: Articles
- URL: https://journals.rcsi.science/2686-7389/article/view/258948
- DOI: https://doi.org/10.31857/S2686738924010164
- EDN: https://elibrary.ru/KMSWSW
- ID: 258948
Cite item
Abstract
Gene editing using the CRISPR/Cas9 system provides new opportunities for the treatment of human diseases. Therefore, it is relevant to develop approaches aimed at increasing the efficiency of genome editing. Here, to increase the level of editing of the CXCR4 locus, a target for gene therapy of HIV infection, the Cas9 protein was modified by introducing additional NLS signals, and the ribonucleoprotein complexes of Cas9 and guide RNA were stabilized with poly-L-glutamic acid. This allowed a 1.8-fold increase in the level of CXCR4 knockout in the CEM/R5 T cell line and a 2-fold increase in the level of knock-in of the HIV-1 fusion peptide inhibitor MT-C34 in primary CD4+ T lymphocytes.
Keywords
Full Text
About the authors
D. S. Golubev
Center for Precision Genome Editing and Genetic Technologies for Biomedicine
Author for correspondence.
Email: natalya.a.kruglova@yandex.ru
Institute of Gene Biology Russioan Academy of Sciences
Russian Federation, MoscowD. S. Komkov
Center for Precision Genome Editing and Genetic Technologies for Biomedicine; Ben-Gurion University of the Negev
Email: natalya.a.kruglova@yandex.ru
Institute of Gene Biology Russioan Academy of Sciences, Department of Physiology and Cell Biology, Faculty of Health Sciences
Russian Federation, Moscow; Be’erSheva, IsraelM. V. Shepelev
Center for Precision Genome Editing and Genetic Technologies for Biomedicine
Email: natalya.a.kruglova@yandex.ru
Institute of Gene Biology Russioan Academy of Sciences
Russian Federation, MoscowD. V. Mazurov
Center for Precision Genome Editing and Genetic Technologies for Biomedicine; University of Minnesota
Email: natalya.a.kruglova@yandex.ru
Institute of Gene Biology Russioan Academy of Sciences, Division of Infectious Diseases and International Medicine, Department of Medicine
Russian Federation, Moscow; Minneapolis, USAN. A. Kruglova
Center for Precision Genome Editing and Genetic Technologies for Biomedicine
Email: natalya.a.kruglova@yandex.ru
Institute of Gene Biology Russioan Academy of Sciences
Russian Federation, MoscowReferences
- Pavlovic K., Tristán-Manzano M., Maldonado-Pérez N., et al. Using Gene Editing Approaches to Fine-Tune the Immune System // Front. Immunol. Frontiers Media SA, 2020. V. 11.
- Shams F., Bayat H., Mohammadian O., et al. Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems // BioImpacts. 2022. V. 12. № 4. P. 371–391.
- Smirnikhina S. A., Zaynitdinova M. I., Sergeeva V. A., et al. Improving Homology-Directed Repair in Genome Editing Experiments by Influencing the Cell Cycle // Int. J. Mol. Sci. 2022. V. 23. № 11. P. 5992.
- Cornu T. I., Mussolino C., Müller M. C., et al. HIV Gene Therapy: An Update // Hum. Gene Ther. Hum Gene Ther. 2021. V. 32. № 1–2. P. 52–65.
- Maslennikova A., Mazurov D. Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection // Front. Cell. Infect. Microbiol. Frontiers Media S. A. 2022. V. 12. P. 880030.
- Hou P., Chen S., Wang S., et al. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection // Sci. Rep. 2015. V. 5. P. 15577.
- Wang Q., Chen S., Xiao Q., et al. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection. // Retrovirology. 2017. V. 14. № 1. P. 51.
- Maslennikova A., Kruglova N., Kalinichenko S., et al. Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41 // MBio. American Society for Microbiology. 2022. V. 13. № 1.
- Kim S., Kim D., Cho S. W., et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins // Genome Res. 2014. V. 24. № 6. P. 1012–1019.
- Maggio I., Zittersteijn H. A., Wang Q., et al. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components // Gene Ther. 2020. V. 27. № 5. P. 209–225.
- Nguyen D. N., Roth T. L., Li P. J., et al. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency // Nat. Biotechnol. 2020. V. 38. № 1. P. 44–49.
- Cong L., Ran F. A., Cox D., et al. Multiplex genome engineering using CRISPR/Cas systems // Science. 2013. V. 339. № 6121. P. 819–823.
- Shui S., Wang S., Liu J. Systematic Investigation of the Effects of Multiple SV40 Nuclear Localization Signal Fusion on the Genome Editing Activity of Purified SpCas9 // Bioengineering. 2022. V. 9. № 2. P. 83.
- Staahl B. T., Benekareddy M., Coulon-Bainier C., et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes // Nat. Biotechnol. 2017. V. 35. № 5. P. 431–434.
- Buckley C. D., Amft N., Bradfield P. F., et al. Persistent Induction of the Chemokine Receptor CXCR4 by TGF-β1 on Synovial T Cells Contributes to Their Accumulation Within the Rheumatoid Synovium // J. Immunol. 2000. V. 165. № 6. P. 3423–3429.
- Shy B. R., Vykunta V. S., Ha A., et al. High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails // Nat. Biotechnol. 2023. V. 41. № 4. P. 521–531.
- Kath J., Du W., Pruene A., et al. Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells // Mol. Ther. Methods Clin. Dev. 2022. V. 25. P. 311–330.
- Mohr M., Damas N., Gudmand-Høyer J., et al. The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells // ACS Synth. Biol. 2023. V. 12. № 2. P. 375–389.
- Oh S. A., Senger K., Madireddi S., et al. High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA // J. Exp. Med. 2022. V. 219. № 5.
- Makkerh J. P.S., Dingwall C., Laskey R. A. Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids // Curr. Biol. 1996. V. 6. № 8. P. 1025–1027.